Menu
Back to Journals » Breast Cancer: Targets and Therapy » Volume 9
Review
Recent advances of cyclin-dependent kinases as potential therapeutic targets in HR+/HER2− metastatic breast cancer: a focus on ribociclib
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 9,134 | Dovepress* | 7,941+ | 1,287 | 9,228 | |
| PubMed Central* | 1,193 | 611 | 1,804 | ||
| Totals | 9,134 | 1,898 | 11,032 | ||
| *Since 6 December 2017 | |||||
View citations on PubMed Central and Google Scholar